NCT02281916View on ClinicalTrials.gov

Safety Study of P28GST Treatment in Crohn's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Crohn's Ileocolitis
Interventions
DRUG

P28GST

3 injections of 100 µg of P28GST within 3 months (one injection per month)

Trial Locations (5)

59037

CHRU, Hôpital Claude Huriez, Lille

Unknown

Centre hospitalier, Amiens

Centre Hospitalier de Boulogne, Boulogne-sur-Mer

Centre Hospitalier Dunkerque, Dunkirk

Centre Hospitalier,, Valenciennes

All Listed Sponsors
collaborator

National Research Agency, France

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT02281916 - Safety Study of P28GST Treatment in Crohn's Disease Patients | Biotech Hunter | Biotech Hunter